BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26603846)

  • 1. Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis.
    Condron ME; Pommier SJ; Pommier RF
    Surgery; 2016 Jan; 159(1):358-65. PubMed ID: 26603846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients.
    Massimino K; Harrskog O; Pommier S; Pommier R
    J Surg Oncol; 2013 Jun; 107(8):842-6. PubMed ID: 23592524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of effective prophylaxis against intraoperative carcinoid crisis.
    Woltering EA; Wright AE; Stevens MA; Wang YZ; Boudreaux JP; Mamikunian G; Riopelle JM; Kaye AD
    J Clin Anesth; 2016 Aug; 32():189-93. PubMed ID: 27290972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mega-dose intravenous octreotide for the treatment of carcinoid crisis: a systematic review.
    Seymour N; Sawh SC
    Can J Anaesth; 2013 May; 60(5):492-9. PubMed ID: 23328959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of Octreotide: Clinical Implications for Anesthesiologists and Associated Risks.
    Borna RM; Jahr JS; Kmiecik S; Mancuso KF; Kaye AD
    Anesthesiol Clin; 2017 Jun; 35(2):327-339. PubMed ID: 28526153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of carcinoid crisis with no perioperative octreotide.
    Wonn SM; Ratzlaff AN; Pommier SJ; McCully BH; Pommier RF
    Surgery; 2022 Jan; 171(1):88-93. PubMed ID: 34226047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discussion.
    Surgery; 2016 Jan; 159(1):365-7. PubMed ID: 26603855
    [No Abstract]   [Full Text] [Related]  

  • 8. Carcinoid tumor and intravenous octreotide infusion during labor and delivery.
    Le BT; Bharadwaj S; Malinow AM
    Int J Obstet Anesth; 2009 Apr; 18(2):182-5. PubMed ID: 19200714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orthotopic liver transplantation for carcinoid tumour metastatic to the liver: anesthetic management.
    Claure RE; Drover DD; Haddow GR; Esquivel CO; Angst MS
    Can J Anaesth; 2000 Apr; 47(4):334-7. PubMed ID: 10764178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of intraoperative carcinoid crises].
    Dralle H
    Chirurg; 2016 Jul; 87(7):610. PubMed ID: 27251478
    [No Abstract]   [Full Text] [Related]  

  • 11. Partial hepatic resections for metastatic neuroendocrine tumors: perioperative outcomes.
    Kinney MAO; Nagorney DM; Clark DF; O'Brien TD; Turner JD; Marienau ME; Schroeder DR; Martin DP
    J Clin Anesth; 2018 Dec; 51():93-96. PubMed ID: 30098573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of the pathophysiology of carcinoid crisis.
    Condron ME; Jameson NE; Limbach KE; Bingham AE; Sera VA; Anderson RB; Schenning KJ; Yockelson S; Harukuni I; Kahl EA; Dewey E; Pommier SJ; Pommier RF
    Surgery; 2019 Jan; 165(1):158-165. PubMed ID: 30415870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours.
    Kinney MA; Warner ME; Nagorney DM; Rubin J; Schroeder DR; Maxson PM; Warner MA
    Br J Anaesth; 2001 Sep; 87(3):447-52. PubMed ID: 11517130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anesthetic considerations and management of a patient with unsuspected carcinoid crisis during hepatic tumor resection.
    Choi CK
    Middle East J Anaesthesiol; 2014 Jun; 22(5):515-8. PubMed ID: 25137869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of acute respiratory distress syndrome responsive to methylene blue during a carcinoid crisis.
    van Diepen S; Sobey A; Lewanczuk R; Singh G; Sidhu S; Zibdawi M; Mullen JC
    Can J Anaesth; 2013 Nov; 60(11):1085-8. PubMed ID: 24037749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of advanced-stage carcinoid tumors: lessons learned.
    Boudreaux JP; Putty B; Frey DJ; Woltering E; Anthony L; Daly I; Ramcharan T; Lopera J; Castaneda W
    Ann Surg; 2005 Jun; 241(6):839-45; discussion 845-6. PubMed ID: 15912033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Update on the anesthetic management of patients with malignant carcinoid syndrome].
    Rodríguez-Cosmen C; Trillo Urrutia L; Pacreu Terradas S; Comps Vicente O; Escolano Villén F
    Rev Esp Anestesiol Reanim; 2005 May; 52(5):291-4. PubMed ID: 15968907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary hepatic carcinoid tumor with carcinoid syndrome and carcinoid heart disease: a case report of a patient on long-term follow-up.
    Tohyama T; Matsui K; Kitagawa K
    Intern Med; 2005 Sep; 44(9):958-62. PubMed ID: 16258211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors.
    Schell SR; Camp ER; Caridi JG; Hawkins IF
    J Gastrointest Surg; 2002; 6(5):664-70. PubMed ID: 12399054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide treatment of carcinoid hypertensive crisis.
    Warner RR; Mani S; Profeta J; Grunstein E
    Mt Sinai J Med; 1994 Sep; 61(4):349-55. PubMed ID: 7969229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.